Literature DB >> 24381121

Evaluation of the Alere D-dimer test for point of care testing.

Johanna Helmersson-Karlqvist1, Bo Karlsson, Annika Fredriksson, Anders Larsson.   

Abstract

The primary care regularly sees patients that have symptoms that could be due to thromboembolic diseases. It would be valuable to be able to rule out deep venous thrombosis or pulmonary embolism using Wells score and a negative D-dimer testing already at the primary care unit. This requires a validated D-dimer assay suitable for primary care use. We compared D-dimer results obtained with the new point of care analyzer Alere Triage(®) and the central hospital laboratory STA-R Evolution analyzer from the same patient samples (n = 102). We also calculated the total coefficient of variation (CV) for the Alere method. The two methods showed a good linear correlation (R(2) = 0.977) and a slope of 0.975. CV for the Alere D-dimer method was well below 10%. The study shows that the Alere D-dimer assay and the central laboratory standard assay show similar results. We suggest that the Alere D-dimer assay could be used in primary care in combination with Wells score to reduce referrals to the emergency unit.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24381121     DOI: 10.1007/s11239-013-1043-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  13 in total

Review 1.  Validation, calibration, and specificity of quantitative D-dimer assays.

Authors:  Carl-Erik Dempfle
Journal:  Semin Vasc Med       Date:  2005-11

2.  D-dimer: standardization versus harmonization.

Authors:  Carl-Erik Dempfle
Journal:  Thromb Haemost       Date:  2006-03       Impact factor: 5.249

Review 3.  Clinical review of pulmonary embolism: diagnosis, prognosis, and treatment.

Authors:  James M Hunt; Todd M Bull
Journal:  Med Clin North Am       Date:  2011-09-22       Impact factor: 5.456

Review 4.  Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future.

Authors:  Giuseppe Lippi; Gianfranco Cervellin; Massimo Franchini; Emmanuel J Favaloro
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

5.  Novel monoclonal antibody that recognizes new neoantigenic determinant of D-dimer.

Authors:  Hyun-Ju Doh; Kyung-Soon Song; Myung-Seo Kang; Doo-Sik Kim; Kyung-Ah Kim; Jemo Kang; Yangsoo Jang; Kwang-Hoe Chung
Journal:  Thromb Res       Date:  2005-09-02       Impact factor: 3.944

Review 6.  Laboratory testing in disseminated intravascular coagulation.

Authors:  Emmanuel J Favaloro
Journal:  Semin Thromb Hemost       Date:  2010-07-07       Impact factor: 4.180

7.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Authors:  Philip S Wells; David R Anderson; Marc Rodger; Melissa Forgie; Clive Kearon; Jonathan Dreyer; George Kovacs; Michael Mitchell; Bernard Lewandowski; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

8.  Implementation of a rapid whole blood D-dimer test in the emergency department of an urban academic medical center: impact on ED length of stay and ancillary test utilization.

Authors:  Elizabeth Lee-Lewandrowski; John Nichols; Elizabeth Van Cott; Ricky Grisson; Abner Louissaint; Theodore Benzer; Kent Lewandrowski
Journal:  Am J Clin Pathol       Date:  2009-09       Impact factor: 2.493

Review 9.  Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic meta-analysis.

Authors:  G J Geersing; K J M Janssen; R Oudega; L Bax; A W Hoes; J B Reitsma; K G M Moons
Journal:  BMJ       Date:  2009-08-14

10.  Novel Biomarkers Associated with Deep Venous Thrombosis: A Comprehensive Review.

Authors:  Dawn M Barnes; Thomas W Wakefield; John E Rectenwald
Journal:  Biomark Insights       Date:  2008-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.